JD
Insider selling
Jakob Dupont sold $107K of Pyxis Oncology, Inc. (PYXS) stock
Jakob Dupont, Dir of Pyxis Oncology, Inc. (PYXS), sold 35,000 shares of PYXS stock worth $107K, per an SEC Form 4 filed Jul 2, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 30, 2026, 2 days before it was made public.
PYXS has moved -22.6% since the trade date, from $3.01 to $2.33 (Sep 30, 2026 close).
- Traded
- Jun 30, 2026
- Disclosed
- Jul 2, 2026
- Filing delay
- 2 days
- Price since
- -22.6%
- Role
- Dir
- Source
- SEC Form 4
More PYXS insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.